Fundai

Alborz Darou Company (DALBER) income statement

Operating revenue through to net profit and earnings per share

Ticker
DALBER
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 9-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/09/30To 1402/09/30To 1401/09/30To 1400/09/30
Operating revenue91,649,64333,982,37618,264,94725,266,20017,153,98810,145,343
Cost of operating revenue-30,939,876-16,873,918-12,447,777-14,343,860-10,117,692-4,991,889
Gross profit (loss)60,709,76717,108,4585,817,17010,922,3407,036,2965,153,454
Selling, general and administrative expenses-3,013,524-1,267,914-510,990-260,256-212,766-148,261
Other income257,45549,36067,987125,32459,31852,448
Other expenses-775,299-69,634-83,034-188,548-49,685-58,388
Operating profit (loss)57,178,39915,820,2705,291,13310,598,8606,833,1634,999,253
Finance costs-6,465,951-5,892,871-4,849,644-2,687,580-1,394,641-1,043,181
Other non-operating income and expenses956,6503,152,4072,390,622539,756502,194385,355
Profit (loss) from continuing operations before tax51,669,09813,079,8062,832,1118,451,0365,940,7164,341,427
Current year tax-10,603,441-1,591,2390-851,568-1,225,143-889,532
Net profit (loss) from continuing operations41,065,65711,488,5672,832,1117,599,4684,715,5733,451,895
Net profit (loss)41,065,65711,488,5672,832,1117,599,4684,715,5733,451,895
Basic earnings (loss) per share2,937 rials824 rials236 rials800 rials1,057 rials1,136 rials
Net earnings (loss) per share, rials2,934 rials821 rials237 rials800 rials717 rials1,121 rials
Capital14,000,00014,000,00012,000,0009,500,0006,580,0003,080,000

Reporting periods

89 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.